Insights

Our mission

Patterns of gut microbiome dysbiosis in patients with inflammatory bowel diseases are inconsistent among published studies, probably owing to the heterogeneity of the disease and given the fact that patients enrolled in research studies are often treated and in remission. Therefore, more microbiome studies in “early” (incident) patients that are treatment-naïve and in high-risk individuals are needed. In addition, the microbiome field has to move from association to rather mechanistic studies in order to understand the actual functions and to also prove the associations that serve as hypotheses.

Institute of Clinical Molecular Biology
Kiel University
Rosalind-Franklin-Str. 12
24105 Kiel

Spokesperson
Prof. Dr. rer. nat. Andre Franke
Fon: +49(0)431-500-15112
a.franke@ikmb-uni-kiel.de

Provisional coordination
Eike Zell
Fon: +49 (0)431 500-15113
e.zell@ikmb.uni-kiel.de

Finances
Natalie Tepling
Fon: +49 (0)431 500-15112
admin2@ikmb.uni-kiel.de

Participating Institutes